Showing 1 - 20 results of 17,823 for search '(((( may 1 decrease ) OR ( _ ((we decrease) OR (mean decrease)) ))) OR ( _ largest decrease ))', query time: 0.68s Refine Results
  1. 1

    Table 1_NSAID use may decrease serum Klotho levels.docx by Jingchao Yan (14079168)

    Published 2025
    “…Objective<p>To validate the hypothesis proposed by previous studies, which suggests that NSAID use may elevate Klotho levels.</p>Method<p>We conducted a cross-sectional study involving 11,626 adults from the National Health and Nutrition Examination Survey (NHANES) 2007-2016. …”
  2. 2
  3. 3

    Supplementary Material for: Longitudinal Decrease in Left Ventricular Size with Age: Impact on Mortality and Cardiovascular Hospitalization by figshare admin karger (2628495)

    Published 2025
    “…This study investigated clinical characteristics and outcomes associated with longitudinal decreases in LV size in this population. Methods: We analyzed echocardiographic data from 6,232 adults with normal baseline left ventricular end-diastolic diameter (LVEDD), with a mean interval of 4.8 years between baseline and follow-up echocardiograms. …”
  4. 4
  5. 5
  6. 6

    Data Sheet 1_Decreased cigarette smoking may partially explain the increased prevalence of antinuclear antibodies in the United States.pdf by Gregg E. Dinse (4500940)

    Published 2025
    “…</p>Discussion<p>Although smoking causes harmful health effects, ANA data are consistent with smoking playing a role in decreasing autoimmunity. Recent vaping among adolescents may partially explain their large increase in ANA prevalence. …”
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Decreased production of antiviral factors in patients infected with SARS-CoV-2 due to reduced TLR7 expression by Julia Cataldo Lima (22811497)

    Published 2025
    “…Innate immunity is a key defense against viral infections and influences disease progression. Similar to SARS-CoV-1, which can suppress interferon (IFN) production to evade the immune response, SARS-CoV-2 May also impair antiviral pathways.…”
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20